
Sign up to save your podcasts
Or


In contrast to traditional monoclonal antibodies or small molecules, hyperbaric oxygen therapy involves a different type of treatment. But is this therapeutic option effective for our ulcerative colitis patients? To better understand this, Dr. Neil Nandi speaks with Dr. Parambir Dulai from Northwestern University to share his research on hyperbaric oxygen therapy.
By ReachMD4.7
1818 ratings
In contrast to traditional monoclonal antibodies or small molecules, hyperbaric oxygen therapy involves a different type of treatment. But is this therapeutic option effective for our ulcerative colitis patients? To better understand this, Dr. Neil Nandi speaks with Dr. Parambir Dulai from Northwestern University to share his research on hyperbaric oxygen therapy.

2,058 Listeners

695 Listeners

496 Listeners

69 Listeners

1 Listeners

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

0 Listeners

0 Listeners

2,442 Listeners

3,332 Listeners

56,419 Listeners

1,153 Listeners

513 Listeners

252 Listeners

217 Listeners

13 Listeners

18 Listeners

33 Listeners